JP2025514802A5 - - Google Patents
Info
- Publication number
- JP2025514802A5 JP2025514802A5 JP2024562083A JP2024562083A JP2025514802A5 JP 2025514802 A5 JP2025514802 A5 JP 2025514802A5 JP 2024562083 A JP2024562083 A JP 2024562083A JP 2024562083 A JP2024562083 A JP 2024562083A JP 2025514802 A5 JP2025514802 A5 JP 2025514802A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- formula
- unsubstituted
- compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263332993P | 2022-04-20 | 2022-04-20 | |
| US63/332,993 | 2022-04-20 | ||
| PCT/US2023/019059 WO2023205206A1 (en) | 2022-04-20 | 2023-04-19 | Lincosamides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025514802A JP2025514802A (ja) | 2025-05-09 |
| JP2025514802A5 true JP2025514802A5 (enExample) | 2026-05-01 |
Family
ID=88420515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562083A Pending JP2025514802A (ja) | 2022-04-20 | 2023-04-19 | リンコサミドおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250270246A1 (enExample) |
| EP (1) | EP4511043A4 (enExample) |
| JP (1) | JP2025514802A (enExample) |
| KR (1) | KR20250006139A (enExample) |
| CN (1) | CN119403559A (enExample) |
| AU (1) | AU2023255378A1 (enExample) |
| CA (1) | CA3249734A1 (enExample) |
| WO (1) | WO2023205206A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026025019A1 (en) | 2024-07-26 | 2026-01-29 | President And Fellows Of Harvard College | Synthesis of macrobicyclic thiolincosamines |
| WO2026043875A1 (en) | 2024-08-20 | 2026-02-26 | President And Fellows Of Harvard College | Synthesis of oxepanoprolines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7361743B2 (en) * | 2004-02-11 | 2008-04-22 | Pfizer Inc | Lincomycin derivatives possessing antibacterial activity |
| CZ307305B6 (cs) * | 2017-03-10 | 2018-05-23 | Mikrobiologický ústav AV ČR, v. v. i. | Linkosamidy, jejich příprava a použití |
| US20230203081A1 (en) * | 2020-05-22 | 2023-06-29 | President And Fellows Of Harvard College | Lincosamide antibiotics and uses thereof |
-
2023
- 2023-04-19 CA CA3249734A patent/CA3249734A1/en active Pending
- 2023-04-19 CN CN202380048014.8A patent/CN119403559A/zh active Pending
- 2023-04-19 KR KR1020247038099A patent/KR20250006139A/ko active Pending
- 2023-04-19 AU AU2023255378A patent/AU2023255378A1/en active Pending
- 2023-04-19 EP EP23792463.4A patent/EP4511043A4/en active Pending
- 2023-04-19 WO PCT/US2023/019059 patent/WO2023205206A1/en not_active Ceased
- 2023-04-19 US US18/858,278 patent/US20250270246A1/en active Pending
- 2023-04-19 JP JP2024562083A patent/JP2025514802A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2850166C (en) | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer | |
| JP5227304B2 (ja) | 新規なヒドロキサム酸誘導体 | |
| JP6518683B2 (ja) | 抗真菌化合物の調製方法 | |
| JP2022544714A5 (enExample) | ||
| JP2021523200A5 (enExample) | ||
| JP2018536015A5 (enExample) | ||
| JP2012524053A5 (enExample) | ||
| JP2013518050A5 (enExample) | ||
| CN110959008A (zh) | 青霉素结合蛋白抑制剂 | |
| CZ151096A3 (en) | 3-aryl-2-isoxazoline-5-hydroxamic acids and pharmaceutical compositions based thereon | |
| JP2019089811A (ja) | 抗真菌化合物の調製方法 | |
| JP2012522759A5 (enExample) | ||
| JP2012512863A (ja) | モノカルバム | |
| MX380516B (es) | Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico | |
| RU2007101703A (ru) | Индолы, полезные при лечении воспаления | |
| AU2014219075B2 (en) | Cis-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer | |
| EP0315518B1 (fr) | Céphalosporines comportant en position 3 un radical vinyle substitué, leur procédé de préparation, leur application comme médicaments, les compositions les renfermant et les intermédiaires obtenus | |
| JP2023547770A5 (enExample) | ||
| CN113365999A (zh) | 含有吡咯并杂环的衣壳蛋白装配抑制剂 | |
| JP2022522890A5 (enExample) | ||
| BR112020016784A2 (pt) | Composto de di-hidropirimidinona ou di-hidropirimidinona condensado ao anel saturado e uso farmacêutico do mesmo | |
| KR20030019399A (ko) | 복소환 유도체 | |
| CA1338090C (en) | Thiazolidin-4-one derivatives and acid addition salts thereof | |
| JPH0324086A (ja) | 結晶質セフェム酸付加塩およびそれらの製法 | |
| CH639388A5 (fr) | Cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl) 2-(carboxymethoxyimino) acetamido/ 3-substitue cephalosporanique, leurs procedes de preparation et medicaments les renfermant. |